Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking [Phase 4]
Phase 4 clinical trial results on counseling and nicotine replacement therapy to help adult smokers quit, including participants with variou…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: A Single-Patient Study Using AGS 006 [NA]
This document reports the completion of a single-patient clinical trial evaluating AGS-006 for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial of bevacizumab plus gemcitabine in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update reporting completion of a study evaluating UCN-01 with gemcitabine in patients with unresectable or metastatic…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial update of CCI-779 (temsirolimus) in locally advanced or metastatic pancreatic cancer; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 clinical trial update announcing completion of a study of the monoclonal antibody ABX-EGF in patients with multiple cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer [Phase 2]
Phase 2 trial of S9700 combination chemotherapy for stage II or III pancreatic cancer has completed; results are not provided in the availab…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine plus imatinib as first-line therapy for locally advanced or metastatic pancreatic cancer has completed …
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer [Phase 3]
A Phase 3 trial compares irofulven to fluorouracil in pancreatic cancer, with the study status listed as completed.
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update of monoclonal antibody RAV12 with gemcitabine in metastatic pancreatic cancer; study terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating stereotactic radiation therapy in combination with chemotherapy for patients undergoing surgery for locall…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
A terminated Stanford trial assessed whether real-time Cine-MRI could feasibly guide treatment of moving and deforming tumors in pancreatic …
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer [Phase 3]
Phase 3 trial evaluating escitalopram for depression in patients with advanced lung or gastrointestinal cancer was terminated; results were …
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma [Phase 1]
Completed Phase I trial evaluating safety and early efficacy of combining sorafenib with gemcitabine and radiotherapy in locally advanced pa…
-
FDA approval · 2012-11-20FDA Approved: CREON — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for CREON (pancrelipase) submitted by AbbVie Inc. The action involves modifications to the produ…
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer [Phase 2]
This document reports the completion of a Phase 2 trial evaluating Erlotinib, Gemcitabine, and Cisplatin in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating radiation therapy plus gadolinium texaphyrin (motexafin gadolinium) in patients with unresectable pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer [Phase 1]
Phase 1 trial of denileukin diftitox followed by vaccine therapy in patients with metastatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 1]
This document summarizes the completed Phase I trial evaluating the combination of capecitabine, gemcitabine, and erlotinib in patients with…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer [Phase 1]
This document reports the completion of the Phase 1 portion of a Phase I/II trial evaluating intratumoral dendritic cell immunotherapy in co…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating apricoxib with gemcitabine and erlotinib for advanced pancreatic cancer; the study is completed and results were po…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer [Phase 3]
Phase III trial comparing Gemcitabine, TS-1, and Gemcitabine plus TS-1 in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating aprepitant to prevent nausea and vomiting in patients undergoing chemotherapy and radiation therapy for pancreatic …
-
CLINICAL_TRIALS research · 2012-10-30Clinical Trial Update: Diagnostic Accuracy of FNA: is Aspiration- Related? [NA]
An update on a clinical trial evaluating the diagnostic accuracy of Fine Needle Aspiration for pancreatic cancer, with unclear status.
-
CLINICAL_TRIALS research · 2012-10-30Clinical Trial Update: C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).
A clinical trial update evaluating C11-labeled erlotinib PET/CT to identify and characterize tumors with high EGFR expression in lung cancer…